Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2026 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2026 Earnings Call Transcript May 13, 2026

Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.44333.

Operator: Good day. Welcome to the Aytu Biopharma Fiscal 2026 Q3 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Robert Blum, Investor Relations. You may begin.

Robert Blum: Great. Thank you very much, and good...